ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

TAVR (TAVI)

November 17, 2014
This is a matched case controlled study of 27 consecutive patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) with the SAPIEN 3 (SV3)device in 2 centers.
November 2, 2014
  The German Aortic Valve Registry comprises data of 78 centers on conventional, transvascular and transapical valve replacements. After stratification for EuroScore and the German AV score, mortality was comparable with either therapy even for high-risk groups. 
September 29, 2014
WASHINGTON D.C. -- September 16, 2014 -- Use of a dual-filter cerebral protection system reduces the number and volume of cerebral lesions in patients with severe aortic stenosis undergoing transaortic valve replacement (TAVR), according to prospective research presented at the 2014 Transcatheter Cardiovascular Therapeutics meeting (TCT).
September 1, 2014
In this retrospective study, the authors evaluate the effect of preprocedural significant mitral regurgitation (MR) on outcomes of patients undergoing transcatheter aortic valve implantation (TAVI) for sever aortic stenosis. In an overall series of 316 patients, 60 had been diagnosed with significant MR prior to the procedure.
September 1, 2014
The authors of this review article provide an extensive overview of the curent state of play in the field of Aortic Stenosis. They discuss risk scores,treatment decisions, and up-to-date evidence of Transcatheter Aortic Valve Replacement.
August 18, 2014
The European system for cardiac operative risk evaluation II (EuroSCORE II) and the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) were validated for overall in-hospital mortality in an US cardiac surgery database comprising >50.000 patients. More reliable results were achieved with the STS-PROM.
August 18, 2014
In this manuscript, the authors describe their experience with the treatment of 8 high risk patients with pure, severe aortic valve regurgitation, using the self-expandable Acurate TA prosthesis  through a transapical approach.
August 18, 2014
In a two-part review, Bax and many other authorities on transcatheter aortic valve implantation (TAVI) provide an extensive overview of the open issues related to patient selection, treatment strategy, and procedural aspects that will help further improve outcomes after TAVI.
August 6, 2014
Bicuspid aortic valve (BAV) stenosis has been regarded as a relative contraindication for transcatheter aortic valve implantation (TAVI).
July 8, 2014
The consortium of authors of this paper determined the survival after Transcatheter valve in valve implantation inside a failed surgical bioprosthesis. The authors report a 1 month mortality rate of 7.6% and a major stroke rate of 1.7%. One-year survival was 83.2%, and 313 (92.6%) of survivors had a good functional status (NYHA I/II).

Pages